Public Procurement and Clinical Outcomes
Following the presentation of clinical outcomes related to public procurement between 2014 and 2016 at the HALMED conference “New Legislation – A New Direction for Medical Devices” by a representative of Johnson & Johnson, which indirectly associated the Instrumentaria hip endoprosthesis with a significant increase in revision surgeries during the public procurement period, Instrumentaria is obliged to present the results of clinical safety and performance evaluations of its hip endoprosthesis. In accordance with Annex X of Council Directive 93/42/EEC on [...]

